Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$37.11 - $50.69 $3,970 - $5,423
-107 Reduced 2.22%
4,711 $226,000
Q1 2024

May 15, 2024

SELL
$40.65 - $65.76 $6,788 - $10,981
-167 Reduced 3.35%
4,818 $231,000
Q4 2023

Feb 14, 2024

SELL
$48.3 - $68.06 $2,608 - $3,675
-54 Reduced 1.07%
4,985 $323,000
Q3 2023

Nov 14, 2023

BUY
$54.2 - $71.67 $85,310 - $112,808
1,574 Added 45.43%
5,039 $329,000
Q2 2023

Aug 14, 2023

BUY
$56.23 - $71.17 $1,911 - $2,419
34 Added 0.99%
3,465 $201,000
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $4,488 - $5,722
84 Added 2.51%
3,431 $211,000
Q4 2022

Feb 13, 2023

BUY
$61.23 - $83.62 $15,491 - $21,155
253 Added 8.18%
3,347 $212,000
Q3 2022

Nov 09, 2022

BUY
$65.58 - $84.69 $202,904 - $262,030
3,094 New
3,094 $224,000

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.